Add BrightSurf on Google Email

Search results for “Oncology”

1,000+ results for "Oncology"

University of Maryland Greenebaum Comprehensive Cancer Center receives $3 million NCI Award to develop next generation of cancer researchers

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has been awarded a $3 million National Cancer Institute Career Development Award to support early-career oncology researchers focused on improving cancer outcomes for patients from diverse backgrounds. The program, called Advancing Oncology Research C...

NRG Oncology/Alliance trial finds immunotherapy did not improve survival when added to chemoradiotherapy for small cell lung cancer

The NRG-LU005 trial found that immunotherapy atezolizumab did not improve survival for patients with limited-stage small cell lung cancer when added to chemoradiation. Twice-daily radiation therapy, however, was associated with improved survival in this population.

SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateMar 12, 2026

The ACHILLES project will train a new generation of researchers in experimental haemato-oncology to tackle leukemia and lymphoma

The ACHILLES project trains researchers in experimental haematological oncology, developing advanced models, analysis tools, and therapeutic targets for leukaemia and lymphoma. The project aims to bridge basic and preclinical research with clinical practice, improving survival rates and accessibility to innovative treatments.

National Foundation for Cancer Research CEO Sujuan Ba Named One of OncoDaily’s 100 Most Influential Oncology CEOs of 2025

Sujuan Ba, CEO of the National Foundation for Cancer Research, has been recognized as one of OncoDaily's 100 Most Influential CEOs in Oncology in 2025. Under her leadership, NFCR has strengthened its role as a strategic accelerator of cancer research, supporting innovative science and fostering cross-sector collaboration.

NRG Oncology adds new leadership members to Brain Tumor, Breast Cancer, Genitourinary Cancer, Lung Cancer, Medical Oncology, Medical Physics, Protocol Operations Monitoring, Publications, and Translational Science committees

NRG Oncology has added several new leadership members to its Brain Tumor, Breast Cancer, Genitourinary Cancer, Lung Cancer, Medical Oncology, and Translational Science committees. Deborah K. Armstrong will lead the NRG Medical Oncology Committee, while Daniel P. Cahill will serve as Surgical Oncology Vice Chair of the NRG Brain Tumor C...

ASTRO relaunches its foundation with a renewed focus and clearer identity to reflect accelerated progress in radiation oncology

The American Society for Radiation Oncology (ASTRO) has rebranded its research foundation as Speed of Light – The ASTRO Foundation, marking a renewed focus on advancing research and improving patient care. The new initiative aims to strengthen research collaborations and investments to drive progress in radiation oncology.

A new study explores why the same mutation in the BRAF gene leads to different therapeutic responses to its inhibitors in melanoma and colorectal cancer

A new study by researchers from the Germans Trias i Pujol Research Institute provides a comparative analysis of the impact of BRAF gene mutations in melanoma and colorectal cancer. The review highlights molecular, cellular, and tumour microenvironment factors that explain the therapeutic dichotomy between the two tumour types.

SourceGermans Trias i Pujol Research Institute·JournalBiochimica et Biophysica Acta·TypeLiterature review·DateDec 22, 2025

UT Health Sciences researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

Researchers at UT Health Sciences Center have developed an AI-enhanced platform called ENRICH, which leverages advanced analytics with community-based human support to reduce treatment interruptions and improve cancer outcomes. The program identifies patients at highest risk for interruption and deploys targeted support resources.

SourceUniversity of Tennessee Health Science Center·TypeData/statistical analysis·DateDec 15, 2025

NRG Oncology adds new leadership members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science committees

Andres M. Álvarez-Pinzón joins NRG Developmental Therapeutics Committee, bringing expertise in oncology clinical trials and translational medicine. Ronald Chen becomes Chair of the NRG Patient Centered Outcomes Research Committee, focusing on improving cancer outcomes through clinical trials and patient-reported outcomes.

ASTRO publishes first clinical guideline on radiation therapy for gastric cancer

The American Society for Radiation Oncology (ASTRO) has published its first clinical guideline on radiation therapy for gastric cancer. The guidelines provide evidence-based recommendations for the role of radiation therapy in multidisciplinary care, including patient selection, integration with systemic therapy and treatment delivery.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·TypeSystematic review·DateNov 18, 2025

From pixels to precision: how large medical imaging models are transforming tumor diagnosis and treatment

Medical imaging foundation models revolutionize cancer precision medicine by integrating multimodal data, AI algorithms, and large language models. They enhance diagnostic accuracy and clinical interpretability, facilitating personalized therapy and intelligent clinical decision support.

SourcePeking Union Medical College Hospital·JournalMedical Journal of Peking Union Medical College Hospital·DateNov 12, 2025

Temporal evolution of large language models in oncology: performance trends of ChatGPT-3.5, ChatGPT-4, and Gemini

This study analyzed the temporal evolution of three LLMs in oncology, finding that subjective questions degrade faster over time than objective queries. The results highlight the need for ongoing performance monitoring and strategies to integrate up-to-date clinical data for safe and reliable AI deployment in cancer care.

SourceFAR Publishing Limited·JournalJournal of Translational Medicine·TypeMeta-analysis·DateNov 9, 2025

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients receiving mRNA-based COVID vaccines showed improved survival rates and responses to immunotherapy, especially in 'cold' tumors with low PD-L1 expression. The study suggests that these vaccines can reprogram immune responses against cancer, potentially improving outcomes for patients with treatment-resistant disease.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature·TypeRandomized controlled/clinical trial·DateOct 19, 2025

Study explores use of religion and spirituality to help patients cope with stress of radiation therapy for gynecologic cancers

Researchers identified specific ways to address religion and spirituality during radiation therapy, highlighting their importance in patient coping mechanisms. The study found that nearly all patients considered spiritual history questions helpful, especially those related to coping with stress.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalPractical Radiation Oncology·DateSep 30, 2025

NRG Oncology trial results show favorable bowel health related quality of life outcomes for localized immediate risk prostate cancer treated with stereotactic body radiation therapy

The NRG-GU005 clinical study shows that SBRT significantly improves bowel health-related quality of life in patients with localized immediate risk prostate cancer. However, no significant improvement was seen for urinary HRQOL, and SBRT was not superior to IMRT in terms of distant-free survival.

Leading cancer societies update clinical guideline on post-mastectomy radiation therapy

The American Society for Radiation Oncology, American Society of Clinical Oncology, and Society of Surgical Oncology jointly published a guideline outlining when post-mastectomy radiation therapy (PMRT) is appropriate based on new evidence. PMRT reduces cancer recurrence risk in patients with node-positive disease or high-risk features.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·TypeSystematic review·DateSep 16, 2025